ICoP 2026 India

Presenters: Maitri Sanghavi, Research Scientist

Co-chair: Suraj Bhansali, Vice President

This session will explore how population-based mechanistic PBPK models implemented within the Simcyp Simulator can significantly improve drug development and regulatory interactions. Drawing on real-world case studies and practical project experiences, the talk will highlight how physiologically based biopharmaceutic and pharmacokinetic modelling can de-risk development, optimize formulation strategy, guide clinical study design, and support regulatory interactions.
Attendees will gain a good understanding of how mechanistic modelling can be integrated into development workflows to enhance efficiency, reduce costs, and support more predictable outcomes in both generic and innovative drug programs.

Presenter: Harshbir Sandhu, Senior Scientist